University of Minnesota Clinical Trials
Sponsors / University of Minnesota
654 ClinicalTrials.gov entries name University of Minnesota as the lead sponsor. Of these, 146 are recruiting, 20 are active without new recruitment, and 415 have completed. The registry records 38 terminated or withdrawn trials for University of Minnesota. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Planned participant enrollment across these trials sums to 140,752. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
654
Total Trials
146
Recruiting
20
Other Active
415
Completed
38
Terminated / Withdrawn
140,752
Total Enrollment
Termination reasons: Other37% · Recruitment32% · Funding18% · PI/or_Site11% · Efficacy3%
Recent Terminations
- Stroke"1. The duration of research tasks exceeded the expected timeframe for uncompensated participants~2. The tDCS system was discontinued and therefore no longer serviced by the manufacturer."
- Acute Kidney Injury"Poor recruitment"
- Alopecia Areata"There was only one participant"
- Spinal Cord Injuries"Never received funding"
- Surgery"PI left institution, no new PI available"
- Hepatocellular Carcinoma"PI Left Institution"
- NCT04406740 Stopped Jun 2021Anesthesia"Device malfunction"
- Cardiac Arrest"For early efficacy"
- PreDiabetes"Only 4 participants completed due to COVID-19 and the many lockdowns. We received a NIH R21 to complete a larger version of this trial and are working on launching this larger trial and submitting it to ClinicalTrials.gov."
- Diet, Healthy"COVID-19"
Active Trials (20 total)
- NCT05843396
- NCT06336655
- NCT06631586
- NCT03587831
- NCT07129070
- NCT03848663
- NCT07546708
- NCT07245615
- Depression NANCT04864080
- NCT05962489
- Conduct Disorder PHASE1/PHASE2NCT06831123
- NCT05656586
- NCT06692920
- Epilepsy PHASE1NCT06016686
- NCT07443891
- NCT07444034
- NCT05205174
- NCT07069400
- Ablation NANCT07094256
- NCT04870970